We are an innovative clinical-stage biopharmaceutical company primarily focused on developing novel therapies to address disabling neuropsychiatric conditions characterized by significant unmet medical need.
$15.00 - $17.00
June 28, 2019
GOLDMAN SACHS & CO. LLC ,CITIGROUP GLOBAL MARKETS INC.,WELLS FARGO SECURITIES, LLC
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for Karuna Therapeutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277